For a safe, personalized experience, trust us with your health
We follow the Obesity Medicine Association Position statement recommendations on Compounded peptides, which recommends that all anti-obesity medications go through clinical testing for safety and efficacy as overseen by the FDA
From compounded peptide GLP-1 therapy: Patients currently using compounded semaglutide or similar GLP-1 peptides from sources like FormBlends should work with their prescriber to plan the transition
Journal Of The American Heart Association 2023, 12: e027225
For women who have spent years feeling stuck with midlife weight gain, reduced mobility, emotional eating or low confidence, that window of opportunity can feel life-changing
REBOUND WEIGHT GAIN AND PERMANENT DEPENDENCY ON SEMAGLUTIDE In clinical trials, semaglutide led to an average weight loss of approximately 15% at 68 weeks among participants without type 2 diabetes, with sustained results observed at the two-year mark